Acacia Research Q2 net loss $61.5M; revenue $16.7M; special committee to review Starboard deal

ACACIA RESEARCH CORP

2022-Q2 EPS reported -$3.06 revenue$30,224,000

GAAP net loss of $61.5M ($1.44/sh) vs net income of $19.7M ($0.23/sh) in Q2 2021.
Total revenue $16.7M (IP $8.1M, Industrial $8.7M) down from $17.4M; operating loss $5.7M.
Repaid $50M of Starboard notes in Q2 and $55M post-quarter; completed $40M share buyback (6.1M shares at avg $4.64).
Realized gains $11.5M; unrealized losses $57.6M; $26.7M milestone from Mycovia FDA approval expected later in 2022.
Board formed special committee to review Starboard relationship; pro forma book value $5.87/sh.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.